<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Commerce and Industry Minister says steps have been taken to sort out the implementation issues related to CEPA and improve bilateral trade as well as trade balance with Japan</title>
    <link>https://www.taxtmi.com/news?id=16701</link>
    <description>Implementation problems in the India-Japan Comprehensive Economic Partnership Agreement (CEPA), chiefly interpretative uncertainty under the rules of origin, are causing loss of preferential tariff treatment for qualifying Indian products. A cited example shows minimal use of an imported cryo-protectant leading to adverse origin findings and disqualification from CEPA benefits. Addressing these origin, certification and implementation frictions is presented as necessary to increase Indian exports-notably pharmaceuticals-and correct the widening trade imbalance with Japan.</description>
    <language>en-us</language>
    <pubDate>Thu, 06 Oct 2016 15:14:36 +0530</pubDate>
    <lastBuildDate>Thu, 06 Oct 2016 15:14:36 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=443971" rel="self" type="application/rss+xml"/>
    <item>
      <title>Commerce and Industry Minister says steps have been taken to sort out the implementation issues related to CEPA and improve bilateral trade as well as trade balance with Japan</title>
      <link>https://www.taxtmi.com/news?id=16701</link>
      <description>Implementation problems in the India-Japan Comprehensive Economic Partnership Agreement (CEPA), chiefly interpretative uncertainty under the rules of origin, are causing loss of preferential tariff treatment for qualifying Indian products. A cited example shows minimal use of an imported cryo-protectant leading to adverse origin findings and disqualification from CEPA benefits. Addressing these origin, certification and implementation frictions is presented as necessary to increase Indian exports-notably pharmaceuticals-and correct the widening trade imbalance with Japan.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Thu, 06 Oct 2016 15:14:36 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=16701</guid>
    </item>
  </channel>
</rss>